Monoclonal Antibody 7C10-C5 Specific for the Novel Cancer Biomarker Methyl-Protein Phosphatase 2A
7C10-C5 can be used to assess methyl-PP2A levels in cancer tissue to diagnose the stage and subtype of disease
Published: 4th April 2022

Patents
- Patent Application: WO2021148681A1
IP Status
- Patent application submitted